Insufficient scRNA-seq data for expression of PHKA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1674.00 | 245 / 245 | 100% | 15.91 | 502 / 502 |
adrenal gland | 100% | 5058.38 | 258 / 258 | 99% | 16.78 | 227 / 230 |
breast | 100% | 1263.41 | 459 / 459 | 98% | 17.39 | 1100 / 1118 |
thymus | 100% | 1619.49 | 653 / 653 | 97% | 15.97 | 585 / 605 |
esophagus | 100% | 1472.76 | 1444 / 1445 | 97% | 11.56 | 177 / 183 |
brain | 97% | 1412.10 | 2565 / 2642 | 99% | 18.22 | 695 / 705 |
uterus | 100% | 939.32 | 170 / 170 | 93% | 9.96 | 426 / 459 |
pancreas | 100% | 1266.80 | 328 / 328 | 92% | 7.02 | 164 / 178 |
bladder | 100% | 1419.10 | 21 / 21 | 90% | 9.26 | 453 / 504 |
intestine | 96% | 930.41 | 929 / 966 | 91% | 9.45 | 477 / 527 |
stomach | 100% | 1624.18 | 359 / 359 | 83% | 8.81 | 236 / 286 |
ovary | 100% | 2424.26 | 180 / 180 | 80% | 5.77 | 343 / 430 |
lung | 84% | 468.88 | 486 / 578 | 95% | 12.04 | 1099 / 1155 |
kidney | 88% | 447.10 | 78 / 89 | 84% | 9.93 | 759 / 901 |
skin | 95% | 769.86 | 1717 / 1809 | 50% | 7.17 | 238 / 472 |
muscle | 100% | 15503.69 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.52 | 1 / 1 |
blood vessel | 100% | 1777.20 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 899.00 | 1194 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 890.94 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 94% | 1126.21 | 813 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 7.96 | 36 / 45 |
eye | 0% | 0 | 0 / 0 | 49% | 4.83 | 39 / 80 |
liver | 30% | 127.09 | 68 / 226 | 17% | 0.93 | 68 / 406 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.42 | 7 / 29 |
peripheral blood | 3% | 13.76 | 26 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0045819 | Biological process | positive regulation of glycogen catabolic process |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0005964 | Cellular component | phosphorylase kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005516 | Molecular function | calmodulin binding |
GO_0004689 | Molecular function | phosphorylase kinase activity |
Gene name | PHKA1 |
Protein name | Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform (Phosphorylase kinase alpha M subunit) Phosphorylase b kinase regulatory subunit |
Synonyms | PHKA |
Description | FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin. FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin. . FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin. . |
Accessions | P46020 ENST00000339490.7 [P46020-2] ENST00000373542.9 [P46020-1] A6NMN0 ENST00000541944.5 [P46020-3] A6NIT2 ENST00000373539.3 ENST00000373545.7 |